These included 177 tumours from 6 cancer types in the HMF dataset [20], and 235 metastatic bladder cancer tumours from the Mariathasan dataset, treated with anti-PDL1 (atezolizumab) [21]. Here, CD274 is linked to urinary bladder cancer.